Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of Mist Nibima and Lucky Herbal Mixture for malaria treatment
PACTR202107733803271Phase 4Not yet recruiting
- Sponsor
- Department of Biomedical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lumefantrine in malaria (3 arms), sponsored by Department of Biomedical Sciences. Primary endpoints: Total parasite clearance by Day 5, Partial parasite clearance by Day 5 and 1 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202107733803271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202107733803271.